BD launches portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes, dramatically expanding access to COVID-19 testing
This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19